KIDS · Orthopediatrics Corp
$19.99
+0.15 (+0.76%)
At close · Jul 29
Market Cap
$513.44M
Shares
25.68M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David Bailey | CEO | $3,331,481 |
| Fred L. Hite | CFO | $2,397,186 |
| Joseph W. Hauser | President of Trauma, Deformity and OPSB | $1,974,862 |
| Gregory A. Odle | President of Scoliosis | $1,498,184 |
| Daniel J. Gerritzen | General Counsel | $1,497,064 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David Bailey | CEO | $3,656,888 |
| Fred L. Hite | CFO | $2,581,018 |
| Joseph W. Hauser | President of Trauma, Deformity and OPSB | $1,739,679 |
| Gregory A. Odle | President of Scoliosis | $1,600,992 |
| Daniel J. Gerritzen | General Counsel | $1,599,958 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David Bailey | CEO | $2,721,840 |
| Fred L. Hite | CFO | $2,036,119 |
| Gregory A. Odle | President of Scoliosis | $1,351,904 |
| Joseph W. Hauser | President of Trauma, Deformity and OPSB | $1,351,904 |
| Daniel J. Gerritzen | General Counsel | $1,351,904 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Bailey | CEO | $1,278,432 |
| Fred L. Hite | CFO | $1,257,052 |
| Gregory A. Odle | President of Scoliosis | $1,049,607 |
| Joseph W. Hauser | President of Trauma, Deformity and OPSB | $1,019,079 |
| Daniel J. Gerritzen | General Counsel | $1,019,079 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David Bailey | CEO | $906,047 |
| Fred L. Hite | CFO | $906,047 |
| Gregory A. Odle | President of Scoliosis | $756,555 |
| Joseph W. Hauser | President of Trauma, Deformity and OPSB | $742,296 |
| Daniel J. Gerritzen | General Counsel | $734,742 |
Key facts
CIK
1425450
CUSIP
68752L100
13F (30d)
21 filings
21 filers
Visit website
Investor relations